TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2025
This article has no abstract
Epistemonikos ID: f89f6beed16cdc125007f910032d4d02e4ece198
First added on: Mar 18, 2025